Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoChange DetectedEnrollment status updated to indicate no recruitment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision label updated to v3.6.0, with a formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, indicating a small revision to the page's history. No substantive content changes are implied.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, representing a small version metadata update to the study record.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdated the ClinicalTrials.gov page revision indicator from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check86 days agoChange DetectedAdded Naples, Italy 80131 to the location list and removed Napoli, Italy 80131; updated Revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.